Search Results for "Eslicarbazepine Acetate In Perephrel Neuritis"
Original Source: Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain
The primary objective of this study is to assess the efficacy of Eslicarbazepine acetate (ESL) as therapy in subjects with Diabetic Neuropathic Pain (DNP) over a 15 week treatment phase.
Matching Channels
On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...
von Willebrand disease (vWD) is the most common hereditary coagulation abnormality described in humans, although it can also be acquired as a result of other medical conditions. It arises from a qua...
Luteinizing hormone (LH), a gonadotropin, stimulates the gonads - in males, the testes, and in females, the ovaries. It is essential for reproduction, and secreted from cells in the anterior pituita...
Matching News
Stedesa eslicarbazepine acetate regulatory update
Zebinix eslicarbazepine acetate regulatory update
Management of Optic Neuritis as a First Event of MS
How common is it for optic neuritis to present in patients with MS, and how is it best diagnosed and treated? Current Opinion in Ophthalmology
Sunovion's Stedesa gets second chance at US FDA
The US FDA accepted for review Sunovion Pharmaceuticals' new drug application for Stedesa (eslicarbazepine acetate), an investigational voltage-gated sodium and T-type calcium channel blocker, for us...
Matching PubMed Articles
A novel, sensitive, selective and stability indicating LC-UV method was developed for the determination of potential impurities of eslicarbazepine acetate. High performance liquid chromatographic inve...
Novel medications for epilepsy.
Despite the introduction of many second-generation antiepileptic drugs (AEDs) in the last 2 decades, the proportion of individuals with pharmacoresistant epilepsy has not been reduced substantially co...
Chiral separation method development was carried out for eslicarbazepine acetate and its (R)-enantiomer on diverse chiral stationary phases. Better chiral selectivity was observed on cellulose tris-(3...
PURPOSE: To compare the bioavailability (BA) and pharmacokinetic (PK) properties and to demonstrate the bioequivalence (BE) between two active product ingredient (API) sources of eslicarbazepine aceta...
Eslicarbazepine acetate in clinical practice. Efficacy and safety results.
INTRODUCTION. Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) licensed in Spain in February 2011 as an adjunctive therapy in adults with partial seizures with or without secondary gene...
